Valid cardiac biomarkers. Part I
Biomarkers are widely used for the diagnosing of diseases, evaluation of their severity, prediction of outcomes, and for monitoring the effectiveness and safety of targeted therapy. This review describes specific cardiac biomarkers approved by FDA (Food and Drug AdministrationбUSA). The list of desc...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2020-09-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2573 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849408653632733184 |
|---|---|
| author | V. A. Metelskaya N. G. Gumanova |
| author_facet | V. A. Metelskaya N. G. Gumanova |
| author_sort | V. A. Metelskaya |
| collection | DOAJ |
| description | Biomarkers are widely used for the diagnosing of diseases, evaluation of their severity, prediction of outcomes, and for monitoring the effectiveness and safety of targeted therapy. This review describes specific cardiac biomarkers approved by FDA (Food and Drug AdministrationбUSA). The list of described biomarkers is not exhaustive. In addition to the general concepts of biomarkers, definitions and classification, this Part I of the review contains data on diagnostic and prognostic biomarkers of cardiovascular diseases associated with atherosclerosis. |
| format | Article |
| id | doaj-art-6d936c33f60e48bdbf39d93f82760a7e |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2020-09-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-6d936c33f60e48bdbf39d93f82760a7e2025-08-20T03:35:44Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252020-09-0119410.15829/1728-8800-2020-25732138Valid cardiac biomarkers. Part IV. A. Metelskaya0N. G. Gumanova1National Medical Center for Therapy and Preventive MedicineNational Medical Center for Therapy and Preventive MedicineBiomarkers are widely used for the diagnosing of diseases, evaluation of their severity, prediction of outcomes, and for monitoring the effectiveness and safety of targeted therapy. This review describes specific cardiac biomarkers approved by FDA (Food and Drug AdministrationбUSA). The list of described biomarkers is not exhaustive. In addition to the general concepts of biomarkers, definitions and classification, this Part I of the review contains data on diagnostic and prognostic biomarkers of cardiovascular diseases associated with atherosclerosis.https://cardiovascular.elpub.ru/jour/article/view/2573circulating biomarkerslaboratory diagnosticsfdacardiovascular diseasesatherosclerosiscoronary artery disease |
| spellingShingle | V. A. Metelskaya N. G. Gumanova Valid cardiac biomarkers. Part I Кардиоваскулярная терапия и профилактика circulating biomarkers laboratory diagnostics fda cardiovascular diseases atherosclerosis coronary artery disease |
| title | Valid cardiac biomarkers. Part I |
| title_full | Valid cardiac biomarkers. Part I |
| title_fullStr | Valid cardiac biomarkers. Part I |
| title_full_unstemmed | Valid cardiac biomarkers. Part I |
| title_short | Valid cardiac biomarkers. Part I |
| title_sort | valid cardiac biomarkers part i |
| topic | circulating biomarkers laboratory diagnostics fda cardiovascular diseases atherosclerosis coronary artery disease |
| url | https://cardiovascular.elpub.ru/jour/article/view/2573 |
| work_keys_str_mv | AT vametelskaya validcardiacbiomarkersparti AT nggumanova validcardiacbiomarkersparti |